$FOCI

提及 11 首次 2026-03-17 最近 2026-06-05

相关推文

按时间倒序

  1. 说明AAOI主要是可插拔光模块敞口,FOCI是其第二喜欢的纯CPO标的。

    回复 @awodias:不是,$AAOI 主要是可插拔光模块敞口。但它也有很大的 CPO 敞口,所以我用了光子学这个词。 如果说第二喜欢的纯 CPO 敞口,我会选 FOCI。

    英文原文

    @awodias No, $AAOI is primarily pluggable exposure. But they have large exposure to CPO too, hence why I included the word photonics. Second favorite pure play CPO exposure would be FOCI for me.

  2. 看多FOCI,认为市场低估CPO瓶颈前景,类似去年AXTI。

    @RayT168 对FOCI非常有信心,市场目前正在低估未来的共封装光学(CPO)瓶颈,就像去年的$AXTI一样。

    英文原文

    @RayT168 Pretty high conviction in FOCI, markets underpricing future CPO bottlenecks right now just like $AXTI last year

  3. 质疑 POET 估值高过 FOCI 的合理性

    为什么 $POET(31.4 亿美元)的估值会比 FOCI(3363,31 亿美元)还高??? FOCI 明明就是 CPO 量产爬坡的瓶颈,也是 $TSM 和 $NVDA 的主要供应商。 我非常看好 FOCI,等机构发现这个名字后,它会跑赢。 另外,FOCI 管理层能不能像 $HIMX 那样去做 NASDAQ ADR?谢谢。

    英文原文

    HOW DOES $POET ($3.14B) HAVE A HIGHER VALUATION THAN FOCI (3363, $3.1B)??? FOCI IS LITERALLY THE BOTTLENECK FOR CPO VOLUME RAMP AND MAIN SUPPLIER FOR $TSM AND $NVDA. High conviction Foci outperforms once institutions find this name. Also, can Foci management please pursue NASDAQ ADR like $HIMX? Thank you.

  4. 认为 FOCI 被严重低估

    FOCI(3363)是现在全市场里被低估最严重的 CPO 玩家之一,市值大概只有 30 亿美元。 它的 BOM 相对市值非常大,而且预计会拿到 $NVDA / $TSM 的主导性份额。 你要到 2027 / 2028 年才会真正看到这件事兑现,虽然我们现在已经进入 2026 年下半年了(这也是我说在提前押注 CPO 超级周期)。

    英文原文

    FOCI (3363) is one of the most undervalued CPO players in the entire market right now at ~$3B. Their BOM is massive relative to MC and they're expected to capture a dominant market share for $NVDA / $TSM. You only start to see this show up 2027 / 2028, even though we're entering H2 2026 now (which is what I mean by frontrunning CPO supercycle).

  5. 看好 FOCI 在未来两年大幅跑赢

    说实话,我预计 FOCI(3363)在接下来两年会远远打爆预期。 这个价位对我来说是中期非常高置信度的持仓。 因为他们预计会成为 $NVDA 和 $TSM 的领先供应商,而且经常被提到是支撑 2028 年 $91B+ CPO TAM 的关键瓶颈(GS)。 太离谱了:一个推动规模化所必需的关键 CPO 瓶颈,市值只有 30 亿美元;而 LightWave Logic 这种还在开发阶段的公司,市值也差不多有 27 亿美元。

    英文原文

    Honestly I’m expecting FOCI (3363) to blow away projections over next two years. It’s a pretty high conviction position for me medium term at this level. Since they’re expected to be the leading supplier to $NVDA and $TSM and get frequently cited as a bottleneck for that $91B+ 2028 CPO TAM (GS). Insane how it’s $3B MC as a critical CPO bottleneck required for scale, while LightWave Logic literally has around the same valuation at $2.7B in development stage.

  6. 市场回调时我手里有些 Foci 头寸也在回撤

    @soulbiri1 在市场回调时机还挺合适! 我现在其实有些名字,比如 Foci,暂时还是亏的。

    英文原文

    @soulbiri1 Good timing while there's a market correction! I'm actually red on some of these names like Foci so far.

  7. 对 CPO 里两个不同 bottleneck 都很看好

    CPO 供应链里有两个不同的 chokepoints / bottlenecks,而且风险结构不一样。我真的、真的都很喜欢。 MSScorps 有潜在的 yield monopoly,市场份额最高可到 90%(基本就是 100%,只是我不想说成反垄断)。这对规模化来说绝对必需。 FOCI 则是 FAU 和光学组件的 bottleneck。 FOCI 可能是一个增长很快、很有吸引力的敞口,而且需求可见度很高。 如果它的竞争对手真被专利打掉,Msscorp 就像一艘从 0 到 100 的火箭。

    英文原文

    Two different chokepoints/bottlenecks in CPO supply chain with different risk profiles. I really, really like both. MSScorps is potential monopoly over yields with up to 90% market share (basically 100% just don’t want antitrust), which is an absolute must for scaling. Foci is a bottleneck over FAU and optical components. Foci is probably a really high growth, compelling exposure with a lot of demand visibility. Msscorp is like a 0 to 100 rocket ship if all their competitors get successfully slapped by patents.

  8. 说明 FOCI 在 CPO 暴露里非常有吸引力

    FOCI(3363)在现在这个位置上,作为 CPO 敞口看起来极具吸引力,市值大概只有 33.5 亿美元。 1. $TSM COUPE 先进封装负责人暗示,FOCI 提供的 FAU 供给会是量产中的大瓶颈。 2. Morgan Stanley note 预计他们会成为 $NVDA 和 $TSM 的领先供应商,市占率最高可到 50%。 3. $HIMX 释放了创纪录需求的信号,而且表示 Foci 应该扩产,这意味着中期需求可见度很高。 4. 根据 Goldman Sachs 的研究,FAU 和光学组件占 CPO 相关 BOM 的很大比例。 5. 总体 CPO TAM 按 GS 的说法,未来两年会从接近 0 增长到 910 亿美元。 方向上我对这个主题非常有信心(NFA),尽管短期市场波动很大。 风险在于后续 generation 被设计替代。 但在未来 1-2 年里,我认为它有很高的重估潜力,相比其他名字也许需要持续跟踪。 只是顺手分享一下我持有的更纯 CPO 敞口思路。

    英文原文

    FOCI (3363) is looks extremely compelling around now at ~$3.35B MC for CPO exposure. 1. $TSM COUPE advanced packaging director hinted that FAU supplies by FOCI be a pretty big bottleneck for mass production. 2. Leading supplier for $NVDA and $TSM expected with up to 50% market share from Morgan Stanley note. 3. $HIMX signaled record demand and that Foci should scale up capacity (meaning high medium term demand visibility) 4. FAU and optical components make a large % of CPO related BOM from Goldman Sachs research note. 5. Overarching CPO tam basically goes from near 0 to $91B in the next two years from the GS note. I’m very confident about this theme directionally over time (NFA), despite any recent market volatility. Risks include getting designed out for later generations. But over the next 1-2 years, I think it has high potential to be re-rated compared to other names but might need to be actively monitored. Just throwing out ideas over long positions I hold, for more purer play CPO exposure.

  9. 说 FOCI 可能排在后面但仍很靠前。

    @MindQuest42 @AstuteKara 不,FOCI 大概排得更后面一点,但仍然算很靠前。

    英文原文

    @MindQuest42 @AstuteKara Nope, FOCI is probably further down the list but still high up there.

  10. 展示CPO/光子学ETF模拟仓YTD表现,等权重投资收益率50%,看好光子学长周期。

    Serenity的Silicon Photonics / CPO ETF模拟仓。各成分股年初至今收益率:$IQE:+282.5%,$AXTI:+246.6%,Landmark:167.54%,$AAOI:+157.37%,$SIVE:+113.08%,$SOI:+103.54%,$LITE:+100.27%,$LWLG:+92.35%,$VIAV:+88.71%,$AIXA:+73.92%,$AEHR:+70.4%,$CIEN:+67.67%,$FORM:+60.67%,$FOCI:+60.44%,$CAMT:+49.13%,$GLW:+46.77%,$SMHN:+45.94%,Fujikura:+43.89%,$COHR:+41.81%,$KEYS:+40.48%,$TSEM:+36.42%,$ASX:+29.89%,$MTSI:+28.34%,$NOK:+27.5%,Shin-Etsu:+27.33%,$ONTO:+26.28%,$BESI:+24.71%,$UMC:+18.11%,$INTC:+17.27%,$OXINF:+15.03%,$FN:+12.79%,Eoptolink:+11.82%,$TSM:+6.00%,$HIMX:+5.39%,$SMTC:+4.11%,Sumitomo:+3.67%,$CSCO:+3.25%,Innolight:+0.33%,$MRVL:+0.16%,$APH:-6.48%,$MXL:-7.62%,$AVGO:-7.99%,$POET:-12.99%,$TEL:-14.93%。这是回顾性的,但你们知道我在很多赢家仓位已经持有一段时间了(例如前六/七名,除了Landmark外的$AXTI或$LITE)。但如果你好奇年初投资整个光子学趋势的话,等权重收益率是多少?50.033%。我预计光子学长周期(supercycle)将持续未来数年,这些名字中的许多将成为未来的大受益者。特别是随着共封装光学(CPO)被用于扩展AI部署。光子学是AI的新架构范式。

    英文原文

    The Serenity Silicon Photonics / CPO ETF. YTD Returns of Each Index Stock: $IQE: +282.5% $AXTI: +246.6% Landmark: 167.54% $AAOI: +157.37% $SIVE: +113.08% $SOI: +103.54% $LITE: +100.27% $LWLG: +92.35% $VIAV: +88.71% $AIXA: +73.92% $AEHR: +70.4% $CIEN: +67.67% $FORM: +60.67% $FOCI: +60.44% $CAMT: +49.13% $GLW: +46.77% $SMHN: +45.94% Fujikura: +43.89% $COHR: +41.81% $KEYS: +40.48% $TSEM: +36.42% $ASX: +29.89% $MTSI: +28.34% $NOK: +27.5% Shin-Etsu: +27.33% $ONTO: +26.28% $BESI: +24.71% $UMC: +18.11% $INTC: +17.27% $OXINF: 15.03% $FN: +12.79% Eoptolink: +11.82% $TSM: +6.00% $HIMX: +5.39% $SMTC: +4.11% Sumitomo: +3.67% $CSCO: +3.25% Innolight: +.33% $MRVL: +.16% $APH: -6.48% $MXL: -7.62% $AVGO: -7.99% $POET: -12.99% $TEL: -14.93% This is retrospectively, but as you've known I've been in a lot of the winners for awhile (eg. Top 6/7 like $AXTI or $LITE aside from Landmark). However, if you were curious if you invested in the photonics trend as a whole at the start of the year. The equal weighted return? 50.033% I expect the Photonic Supercycle to last over the next several years, and many of these names to be large beneficaries going forward. Especially as CPO is used to scale AI deployments. Photonics is the new architectural paradigm for AI.